Hépato-Gastro & Oncologie Digestive
Agenda
Volume 32, supplement 2, June 2025
News from the GTE 2024 Congress. The role of internal vectored radiotherapy in metastatic neuroendocrine tumors. Endocrine Tumor Study Group, November 21 and 22, 2024 - Paris
Numéro réalisé avec le soutien institutionnel des laboratoires Advanced Accelerator Applications
Volume 32, supplement 2, June 2025
MINI-REVUE
Peptide receptor radionuclide therapy in metastatic neuroendocrine tumors: today’s advancements... and tomorrow?
(p.5-9)
Anna Pellat, Lisa Lellouche
SYNTHÈSE DES COMMUNICATIONS
Highlights in digestive neuroendocrine neoplasms from the GTE congress 2024
(p.10-6)
Anna Pellat, Lisa Lellouche